Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin E for Oxaliplatin-induced Neuropathy Prophylaxis
NCT01523574Phase 2Completed
- Start
- Aug 2009
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vitamin e in peripheral neuropathy. Primary endpoint: Incidence and grade of Peripheral neuropathy by CTCAE v 3.0 and specific Ox PN gradation scales at 45 days. Started Aug 2009; status: completed.
02
Drugs
vitamin e
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT01523574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01523574.